casperz
Experienced Member
- Reaction score
- 25
The drug can cut the odds of being diagnosed with prostate cancer by about 25 percent. Earlier worries that it might spur aggressive tumors have largely faded with further study, making doctors more willing to recommend it now.
http://www.msnbc.msn.com/id/29372254/
